Epidemiology of non-Hodgkin lymphoma

Pamela Skrabek; Donna Turner; Matthew Seftel

doi:10.1016/j.transci.2013.07.014

Epidemiology of non-Hodgkin lymphoma

Transfus Apher Sci. 2013 Oct;49(2):133-8. doi: 10.1016/j.transci.2013.07.014. Epub 2013 Aug 16.

Authors

Pamela Skrabek¹, Donna Turner, Matthew Seftel

Affiliation

¹ Department of Medical Oncology and Haematology, CancerCare Manitoba, Canada; Department of Community Health Sciences, University of Manitoba, Canada. Electronic address: pamela.skrabek@cancercare.mb.ca.

PMID: 23958141
DOI: 10.1016/j.transci.2013.07.014

Abstract

Non-Hodgkin Lymphoma (NHL) occurs worldwide although there is notable geographical variation in incidence and subtype distribution. These differences are due to a combination of demographic, environmental and other unidentified factors. A dramatic increase in NHL incidence was seen starting around 1970, with subsequent stabilization 10 years ago. Despite this plateau, the number of new cases in many countries will increase significantly in coming years due primarily to aging populations. In the majority of cases, strong risk factors are not identifiable. There is significant epidemiological heterogeneity between NHL subtypes, yet cancer registries have tended to consider NHL as a single entity. This is one of several epidemiological obstacles discussed.

Keywords: Epidemiology; Etiology; Non-Hodgkin Lymphoma (NHL).

Publication types

Review

MeSH terms

Age Factors
Humans
Lymphoma, Non-Hodgkin / epidemiology*